Infectieux 333
de microbiologie et de pharmacie. Des textes existent, permettant de s’appuyer
sur une base cohérente pour construire une «paquet» de mesures limitantes. Ce
sont ainsi les médecins prescripteurs qui décident de l’écologie de leur service:
limiter l’antibiothérapie entraîne une diminution de la pression de sélection, donc
l’apparition de BMR et donc l’utilisation de molécules à large spectre. Un cercle
vertueux peut se créer, bénéque pour toute la communauté (patients, hôpital,
médecins…). Cette dynamique ne peut exister que si l’ensemble des intervenants
est convaincu de l’intérêt d’une telle prise en charge et de l'épargne antibiotique.
RÉFÉRENCES BIBLIOGRAPHIQUES
[1] Carlet J. Ten tips on how to win the war against resistance to antibiotics. Intensive Care Med.
2015 May;41(5):899-901.
[2] Vincent JL, Rello J, Marshall and coll. International study of the prevalence and outcomes of
infection in intensive care units. JAMA. 2009 Dec 2;302(21):2323-9.
[3] Luyt CE, Bréchot N, Trouillet JL, Chastre J. Antibiotic stewardship in the intensive care unit. Crit
Care. 2014 Aug 13;18(5):480.
[4] Bassetti M, Poulakou G, Timsit JF. Focus on antimicrobial use in the era of increasing antimicrobial
resistance in ICU. Intensive Care Med. 2016 Apr 4. [Epub ahead of print].
[5] Roberts JA, Paul SK, Akova M, Bassetti M, and coll. DALI: dening antibiotic levels in intensive
care unit patients: are current β-lactam antibiotic doses sufcient for critically ill patients? Clin Infect
Dis. 2014 Apr;58(8):1072-83.
[6] de Montmollin E, Bouadma L, Gault N, and coll. Predictors of insufcient amikacin peak concen-
tration in critically ill patients receiving a 25 mg/kg total body weight regimen. Intensive Care Med.
2014 Jul;40(7):998-1005.
[7] http://ecdc.europa.eu/en/healthtopics/antimicrobial_resistance/database/Pages/database.aspx
[8] Bretonnière C, Leone M, Milési C and coll. Strategies to reduce curative antibiotic therapy in
intensive care units (adult and paediatric). Intensive Care Med. 2015 Jul;41(7):1181-96.
[9] Dellinger RP, Levy MM, Rhodes A and coll. Surviving Sepsis Campaign: international guidelines for
management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013 Feb;39(2):165-228.
[10 Kumar A, Roberts D, Wood KE. Duration of hypotension before initiation of effective antimicrobial
therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006 Jun;34(6):1589-
96.
[11] Bloos F, Thomas-Rüddel D, Rüddel H and coll. Impact of compliance with infection management
guidelines on outcome in patients with severe sepsis: a prospective observational multi-center study.
Crit Care. 2014 Mar 3;18(2):R42.
[12] de Groot B, Ansems A, Gerling DH and coll. The association between time to antibiotics and
relevant clinical outcomes in emergency department patients with various stages of sepsis: a pros-
pective multi-center study. Crit Care. 2015 Apr 29;19:194.
[13] Puskarich MA, Trzeciak S, Shapiro NI and coll. Association between timing of antibiotic adminis-
tration and mortality from septic shock in patients treated with a quantitative resuscitation protocol.
Crit Care Med. 2011 Sep;39(9):2066-71.
[14] Sterling SA, Miller WR, Pryor J and coll. The Impact of Timing of Antibiotics on Outcomes in
Severe Sepsis and Septic Shock: A Systematic Review and Meta-Analysis. Crit Care Med. 2015
Sep;43(9):1907-15.
[15] Leblanc PE, Ract C, Fortineau N. Optimisation des prélèvements bactériologiques en réanimation.
In Mapar 2008;173-178.
[16] de la Poza Abad M, Mas Dalmau G, Moreno Bakedano M and coll. Prescription Strategies in
Acute Uncomplicated Respiratory Infections: A Randomized Clinical Trial. JAMA Intern Med. 2016 Jan
1;176(1):21-9.
[17] Montravers P, Augustin P, Grall N and coll. Characteristics and outcomes of anti-infective de-
escalation during health care-associated intra-abdominal infections. Crit Care. 2016 Apr 7;20(1):83.